维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

15篇 您的检索式：作者名="Moiseyenko D D"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	KRAS status and efficacy in the first -line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: the CRYSTAL experience 显示文摘	Van Cutsem E Lang I D' haens G Moiseyenko V Zaluski J Fol- precht G	2008	J Gin Oncol2008，2620，2：	1
	2	Possibility of computer-aided design of high-porous and framework materials on the basis of Movable Cellular Automata method 显示文摘	Psakhie S G Moiseyenko D D Dmitriev A I	1998	Pis May Zhurn Telehn Fiz1998，24，4：	1
	3	Phase Ⅲ Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Flaorouracil As First - Line Therapy for Advanced Gastric Cancer:A Report of the V325 Study Group显示文摘	Van Cutsem E Moiseyenko VM Tjulandin D	2006	J Clin Oncol2006，24，31：	1
	4	A randomized phase Ⅱ study of Xeloda (capecitabine) vs CMF as first line chemotherapy of breast cancer in women aged≥55 years显示文摘	O'shaughnessy J Moiseyenko V Bell D	1998	Proc Am Soc Clin Oncol1998，17，：	1
	5	Randomised, phase Ⅱ trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines 显示文摘	Talbot D C Moiseyenko V Van Belle S	2002	Br J Cancer2002，86，9：	1
	6	Survival benefit with eapecitabine/docetaxel versus docetaxel alone:analysis of therapy in a randomized phase Ⅲ trial显示文摘	Miles D Vukelja S Moiseyenko V	2004	Clin Breast Cancer2004，5，4：	1
	7	Survival benefit with capecitabine/docetaxel versus docetaxel alone: analysis of therapy in a randomized phase Ⅲ trial显示文摘	Miles D Vukelja S Moiseyenko V	2004	Clin Breast Cancer2004，5，4：	1
	8	Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase Ⅲ trial of advanced gastric or gastroesophageal cancer adenocarcinoma : the V325 Study Group 显示文摘	Ajani JA Moiseyenko VM Tjulandin D	2007	Ann Oncol2007，25，：	1
	9	Survival benefit with eapeeitabine/doeetaxel versus doeetaxel alone: analysis of therapy in a randomized phase Ⅲ trial显示文摘	Miles D Vukelja S Moiseyenko V	2004	Clin Breast Cancer2004，5，4：	1
	10	randomized,phase Ⅱ trial comparing oral capeeitabine(Xeloda)with paclitaxeI in patients with metastatic/advanced breast cancer pletreated with anthracyclined显示文摘	TALBOT D C MOISEYENKO V VAN BELLE S	2002	Br J Cancer2002，86，9：	1
	11	Clinical benefit with doc- etaxel plus fluorouracil and cisplatin compared with cisplatin and fluo- rouracil in a phase Ill trial of advanced gastric or gastroesophageal can- cer adenocarcinoma: the V325 Study Group显示文摘	Ajani JA Moiseyenko VM Tjulandin D	2007	Ann Oncol2007，25，：	1
	12	Survival benefit with capecitabine/docetaxel versus docetaxel alone: analysis of therapy in a randomized phase Ⅲ trial显示文摘	Miles D Vukelja S Moiseyenko V	2004	Clin Breast Cancer2004，5，4：	1
	13	Phase m study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer, a report of the V325 study group 显示文摘	Van Cutsem E Moiseyenko VM Tjulandin D	2006	J Clin Oncol2006，24，31：	1
	14	Survival benefit with capecitabine/docetaxel versus docetaxel alone:analysis of therapy in a randomized phase III trial显示文摘	Miles D Vukelja S Moiseyenko V	2004	Clin Breast Cancer2004，5，4：	1
	15	An Economic Coatinuous Calculation Screme for the Stefan Multidimen- sional Problem显示文摘	SAMARSKII A A MOISEYENKO B D	1965	USSR Computational Mathematics and Mathematical Physics1965，5，5：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费